LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatism: A report by the american academy of ophthalmology
To describe LASIK for hyperopia, hyperopia with astigmatism, and mixed astigmatism and to examine the evidence to answer questions about the safety and efficacy of the procedure. A literature search conducted for the years 1968 to 2002 retrieved 118 citations. During review and preparation of this a...
Gespeichert in:
Veröffentlicht in: | Ophthalmology (Rochester, Minn.) Minn.), 2004-08, Vol.111 (8), p.1604-1617 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1617 |
---|---|
container_issue | 8 |
container_start_page | 1604 |
container_title | Ophthalmology (Rochester, Minn.) |
container_volume | 111 |
creator | Varley, Gary A Huang, David Rapuano, Christopher J Schallhorn, Steven Boxer Wachler, Brian S Sugar, Alan |
description | To describe LASIK for hyperopia, hyperopia with astigmatism, and mixed astigmatism and to examine the evidence to answer questions about the safety and efficacy of the procedure.
A literature search conducted for the years 1968 to 2002 retrieved 118 citations. During review and preparation of this article, an additional 2 articles were included. The panel members selected 36 articles for the panel methodologist to review and rate according to the strength of evidence. A level I rating is assigned to properly conducted, well-designed, randomized clinical trials; a level II rating to well-designed cohort and case–control studies; and a level III rating to case series, case reports, and poorly designed prospective and retrospective studies.
This assessment describes 5 nonrandomized interventional trials (level II), 3 nonrandomized comparative trials (level III), and 20 noncomparative case series (level III). Additionally, 6 single-case reports (level III) were included because they reported relevant complications, and 2 theoretical analyses (level III) were also considered. This assessment does not compare studies because many variables such as range of hyperopia, follow-up periods, lasers, microkeratomes, techniques, and surgeon experience have not been controlled.
For low (4 to 5 D). Utilizing hyperopic LASIK for the treatment of consecutive hyperopia and astigmatism is also effective, although the ability to reduce hyperopic astigmatism after radial keratotomy is limited. Although a variety of ablation profiles can be used to treat mixed astigmatism, very good visual results have been reported (levels II and III evidence). Serious adverse complications leading to permanent visual loss are possible but, fortunately, very rare. There are insufficient data to compare one laser system with another or one ablation profile |
doi_str_mv | 10.1016/j.ophtha.2004.05.016 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_66766215</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0161642004008176</els_id><sourcerecordid>66766215</sourcerecordid><originalsourceid>FETCH-LOGICAL-e292t-d6124a0a30861eab365f9047bce478b7584581d8519e9b981cedf1e82f94c28b3</originalsourceid><addsrcrecordid>eNpNkUFv1DAQhS0EotvCP0DIFzg1wXZsx-ZQaVUVqFiJA3C2HGfS9SqOg-1F5N-TahfU04yePo3evIfQG0pqSqj8cKjjvC97WzNCeE1EvYrP0IYKrive0uY52qwKrSRn5AJd5nwghEjZ8JfoggqmlNZig8pu-_3-Kx5iwvtlhhRnb6__rw7bXPxDsMXncI3t1OPg_0D_VP6ItzjBHFPB3YLLHrANkLyzE7bO9hAWHAd88jqGOMaH5RV6Mdgxw-vzvEI_P939uP1S7b59vr_d7ipgmpWql5RxS2xDlKRgu0aKQRPedg54q7pWKC4U7ZWgGnSnFXXQDxQUGzR3THXNFXp_ujun-OsIuZjgs4NxtBPEYzZStlIyKlbw7Rk8dgF6MycfbFrMv5xW4N0ZsNnZcUh2cj4_4XSrtKQrd3PiYH3rt4dksvMwrcZ8AldMH72hxDwWaA7mFIp5LNAQYVax-QvAj48V</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66766215</pqid></control><display><type>article</type><title>LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatism: A report by the american academy of ophthalmology</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Varley, Gary A ; Huang, David ; Rapuano, Christopher J ; Schallhorn, Steven ; Boxer Wachler, Brian S ; Sugar, Alan</creator><creatorcontrib>Varley, Gary A ; Huang, David ; Rapuano, Christopher J ; Schallhorn, Steven ; Boxer Wachler, Brian S ; Sugar, Alan ; Ophthalmic Technology Assessment Committee Refractive Surgery Panel, Ameican Academy of Ophthalmology</creatorcontrib><description>To describe LASIK for hyperopia, hyperopia with astigmatism, and mixed astigmatism and to examine the evidence to answer questions about the safety and efficacy of the procedure.
A literature search conducted for the years 1968 to 2002 retrieved 118 citations. During review and preparation of this article, an additional 2 articles were included. The panel members selected 36 articles for the panel methodologist to review and rate according to the strength of evidence. A level I rating is assigned to properly conducted, well-designed, randomized clinical trials; a level II rating to well-designed cohort and case–control studies; and a level III rating to case series, case reports, and poorly designed prospective and retrospective studies.
This assessment describes 5 nonrandomized interventional trials (level II), 3 nonrandomized comparative trials (level III), and 20 noncomparative case series (level III). Additionally, 6 single-case reports (level III) were included because they reported relevant complications, and 2 theoretical analyses (level III) were also considered. This assessment does not compare studies because many variables such as range of hyperopia, follow-up periods, lasers, microkeratomes, techniques, and surgeon experience have not been controlled.
For low (<3 diopters [D]) to moderate (3–5 D) hyperopia, results from published studies (levels II and III evidence) have shown that LASIK is effective and predictable in achieving very good to excellent uncorrected visual acuity, achieving postoperative refractions within 1 D of emmetropia, and is safe in terms of minimal loss of best-corrected spectacle vision. Although there are fewer data for hyperopic astigmatism, the results available seem to mirror the data for low to moderate hyperopia (levels II and III evidence). The postoperative results for both uncorrected vision and safety are less compelling, as greater amounts of hyperopia are treated (>4 to 5 D). Utilizing hyperopic LASIK for the treatment of consecutive hyperopia and astigmatism is also effective, although the ability to reduce hyperopic astigmatism after radial keratotomy is limited. Although a variety of ablation profiles can be used to treat mixed astigmatism, very good visual results have been reported (levels II and III evidence). Serious adverse complications leading to permanent visual loss are possible but, fortunately, very rare. There are insufficient data to compare one laser system with another or one ablation profile with another.</description><identifier>ISSN: 0161-6420</identifier><identifier>EISSN: 1549-4713</identifier><identifier>DOI: 10.1016/j.ophtha.2004.05.016</identifier><identifier>PMID: 15288995</identifier><identifier>CODEN: OPHTDG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Academies and Institutes ; Astigmatism - surgery ; Biological and medical sciences ; Clinical Trials as Topic ; Cornea - surgery ; Humans ; Hyperopia - surgery ; Keratomileusis, Laser In Situ - methods ; Medical sciences ; Ophthalmology ; Societies, Medical ; Technology Assessment, Biomedical ; Treatment Outcome ; United States ; Vision disorders ; Visual Acuity</subject><ispartof>Ophthalmology (Rochester, Minn.), 2004-08, Vol.111 (8), p.1604-1617</ispartof><rights>2004 American Academy of Ophthalmology</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0161642004008176$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15978961$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15288995$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Varley, Gary A</creatorcontrib><creatorcontrib>Huang, David</creatorcontrib><creatorcontrib>Rapuano, Christopher J</creatorcontrib><creatorcontrib>Schallhorn, Steven</creatorcontrib><creatorcontrib>Boxer Wachler, Brian S</creatorcontrib><creatorcontrib>Sugar, Alan</creatorcontrib><creatorcontrib>Ophthalmic Technology Assessment Committee Refractive Surgery Panel, Ameican Academy of Ophthalmology</creatorcontrib><title>LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatism: A report by the american academy of ophthalmology</title><title>Ophthalmology (Rochester, Minn.)</title><addtitle>Ophthalmology</addtitle><description>To describe LASIK for hyperopia, hyperopia with astigmatism, and mixed astigmatism and to examine the evidence to answer questions about the safety and efficacy of the procedure.
A literature search conducted for the years 1968 to 2002 retrieved 118 citations. During review and preparation of this article, an additional 2 articles were included. The panel members selected 36 articles for the panel methodologist to review and rate according to the strength of evidence. A level I rating is assigned to properly conducted, well-designed, randomized clinical trials; a level II rating to well-designed cohort and case–control studies; and a level III rating to case series, case reports, and poorly designed prospective and retrospective studies.
This assessment describes 5 nonrandomized interventional trials (level II), 3 nonrandomized comparative trials (level III), and 20 noncomparative case series (level III). Additionally, 6 single-case reports (level III) were included because they reported relevant complications, and 2 theoretical analyses (level III) were also considered. This assessment does not compare studies because many variables such as range of hyperopia, follow-up periods, lasers, microkeratomes, techniques, and surgeon experience have not been controlled.
For low (<3 diopters [D]) to moderate (3–5 D) hyperopia, results from published studies (levels II and III evidence) have shown that LASIK is effective and predictable in achieving very good to excellent uncorrected visual acuity, achieving postoperative refractions within 1 D of emmetropia, and is safe in terms of minimal loss of best-corrected spectacle vision. Although there are fewer data for hyperopic astigmatism, the results available seem to mirror the data for low to moderate hyperopia (levels II and III evidence). The postoperative results for both uncorrected vision and safety are less compelling, as greater amounts of hyperopia are treated (>4 to 5 D). Utilizing hyperopic LASIK for the treatment of consecutive hyperopia and astigmatism is also effective, although the ability to reduce hyperopic astigmatism after radial keratotomy is limited. Although a variety of ablation profiles can be used to treat mixed astigmatism, very good visual results have been reported (levels II and III evidence). Serious adverse complications leading to permanent visual loss are possible but, fortunately, very rare. There are insufficient data to compare one laser system with another or one ablation profile with another.</description><subject>Academies and Institutes</subject><subject>Astigmatism - surgery</subject><subject>Biological and medical sciences</subject><subject>Clinical Trials as Topic</subject><subject>Cornea - surgery</subject><subject>Humans</subject><subject>Hyperopia - surgery</subject><subject>Keratomileusis, Laser In Situ - methods</subject><subject>Medical sciences</subject><subject>Ophthalmology</subject><subject>Societies, Medical</subject><subject>Technology Assessment, Biomedical</subject><subject>Treatment Outcome</subject><subject>United States</subject><subject>Vision disorders</subject><subject>Visual Acuity</subject><issn>0161-6420</issn><issn>1549-4713</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkUFv1DAQhS0EotvCP0DIFzg1wXZsx-ZQaVUVqFiJA3C2HGfS9SqOg-1F5N-TahfU04yePo3evIfQG0pqSqj8cKjjvC97WzNCeE1EvYrP0IYKrive0uY52qwKrSRn5AJd5nwghEjZ8JfoggqmlNZig8pu-_3-Kx5iwvtlhhRnb6__rw7bXPxDsMXncI3t1OPg_0D_VP6ItzjBHFPB3YLLHrANkLyzE7bO9hAWHAd88jqGOMaH5RV6Mdgxw-vzvEI_P939uP1S7b59vr_d7ipgmpWql5RxS2xDlKRgu0aKQRPedg54q7pWKC4U7ZWgGnSnFXXQDxQUGzR3THXNFXp_ujun-OsIuZjgs4NxtBPEYzZStlIyKlbw7Rk8dgF6MycfbFrMv5xW4N0ZsNnZcUh2cj4_4XSrtKQrd3PiYH3rt4dksvMwrcZ8AldMH72hxDwWaA7mFIp5LNAQYVax-QvAj48V</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>Varley, Gary A</creator><creator>Huang, David</creator><creator>Rapuano, Christopher J</creator><creator>Schallhorn, Steven</creator><creator>Boxer Wachler, Brian S</creator><creator>Sugar, Alan</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20040801</creationdate><title>LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatism: A report by the american academy of ophthalmology</title><author>Varley, Gary A ; Huang, David ; Rapuano, Christopher J ; Schallhorn, Steven ; Boxer Wachler, Brian S ; Sugar, Alan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e292t-d6124a0a30861eab365f9047bce478b7584581d8519e9b981cedf1e82f94c28b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Academies and Institutes</topic><topic>Astigmatism - surgery</topic><topic>Biological and medical sciences</topic><topic>Clinical Trials as Topic</topic><topic>Cornea - surgery</topic><topic>Humans</topic><topic>Hyperopia - surgery</topic><topic>Keratomileusis, Laser In Situ - methods</topic><topic>Medical sciences</topic><topic>Ophthalmology</topic><topic>Societies, Medical</topic><topic>Technology Assessment, Biomedical</topic><topic>Treatment Outcome</topic><topic>United States</topic><topic>Vision disorders</topic><topic>Visual Acuity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Varley, Gary A</creatorcontrib><creatorcontrib>Huang, David</creatorcontrib><creatorcontrib>Rapuano, Christopher J</creatorcontrib><creatorcontrib>Schallhorn, Steven</creatorcontrib><creatorcontrib>Boxer Wachler, Brian S</creatorcontrib><creatorcontrib>Sugar, Alan</creatorcontrib><creatorcontrib>Ophthalmic Technology Assessment Committee Refractive Surgery Panel, Ameican Academy of Ophthalmology</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Ophthalmology (Rochester, Minn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Varley, Gary A</au><au>Huang, David</au><au>Rapuano, Christopher J</au><au>Schallhorn, Steven</au><au>Boxer Wachler, Brian S</au><au>Sugar, Alan</au><aucorp>Ophthalmic Technology Assessment Committee Refractive Surgery Panel, Ameican Academy of Ophthalmology</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatism: A report by the american academy of ophthalmology</atitle><jtitle>Ophthalmology (Rochester, Minn.)</jtitle><addtitle>Ophthalmology</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>111</volume><issue>8</issue><spage>1604</spage><epage>1617</epage><pages>1604-1617</pages><issn>0161-6420</issn><eissn>1549-4713</eissn><coden>OPHTDG</coden><abstract>To describe LASIK for hyperopia, hyperopia with astigmatism, and mixed astigmatism and to examine the evidence to answer questions about the safety and efficacy of the procedure.
A literature search conducted for the years 1968 to 2002 retrieved 118 citations. During review and preparation of this article, an additional 2 articles were included. The panel members selected 36 articles for the panel methodologist to review and rate according to the strength of evidence. A level I rating is assigned to properly conducted, well-designed, randomized clinical trials; a level II rating to well-designed cohort and case–control studies; and a level III rating to case series, case reports, and poorly designed prospective and retrospective studies.
This assessment describes 5 nonrandomized interventional trials (level II), 3 nonrandomized comparative trials (level III), and 20 noncomparative case series (level III). Additionally, 6 single-case reports (level III) were included because they reported relevant complications, and 2 theoretical analyses (level III) were also considered. This assessment does not compare studies because many variables such as range of hyperopia, follow-up periods, lasers, microkeratomes, techniques, and surgeon experience have not been controlled.
For low (<3 diopters [D]) to moderate (3–5 D) hyperopia, results from published studies (levels II and III evidence) have shown that LASIK is effective and predictable in achieving very good to excellent uncorrected visual acuity, achieving postoperative refractions within 1 D of emmetropia, and is safe in terms of minimal loss of best-corrected spectacle vision. Although there are fewer data for hyperopic astigmatism, the results available seem to mirror the data for low to moderate hyperopia (levels II and III evidence). The postoperative results for both uncorrected vision and safety are less compelling, as greater amounts of hyperopia are treated (>4 to 5 D). Utilizing hyperopic LASIK for the treatment of consecutive hyperopia and astigmatism is also effective, although the ability to reduce hyperopic astigmatism after radial keratotomy is limited. Although a variety of ablation profiles can be used to treat mixed astigmatism, very good visual results have been reported (levels II and III evidence). Serious adverse complications leading to permanent visual loss are possible but, fortunately, very rare. There are insufficient data to compare one laser system with another or one ablation profile with another.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>15288995</pmid><doi>10.1016/j.ophtha.2004.05.016</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0161-6420 |
ispartof | Ophthalmology (Rochester, Minn.), 2004-08, Vol.111 (8), p.1604-1617 |
issn | 0161-6420 1549-4713 |
language | eng |
recordid | cdi_proquest_miscellaneous_66766215 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Academies and Institutes Astigmatism - surgery Biological and medical sciences Clinical Trials as Topic Cornea - surgery Humans Hyperopia - surgery Keratomileusis, Laser In Situ - methods Medical sciences Ophthalmology Societies, Medical Technology Assessment, Biomedical Treatment Outcome United States Vision disorders Visual Acuity |
title | LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatism: A report by the american academy of ophthalmology |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T03%3A31%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=LASIK%20for%20hyperopia,%20hyperopic%20astigmatism,%20and%20mixed%20astigmatism:%20A%20report%20by%20the%20american%20academy%20of%20ophthalmology&rft.jtitle=Ophthalmology%20(Rochester,%20Minn.)&rft.au=Varley,%20Gary%20A&rft.aucorp=Ophthalmic%20Technology%20Assessment%20Committee%20Refractive%20Surgery%20Panel,%20Ameican%20Academy%20of%20Ophthalmology&rft.date=2004-08-01&rft.volume=111&rft.issue=8&rft.spage=1604&rft.epage=1617&rft.pages=1604-1617&rft.issn=0161-6420&rft.eissn=1549-4713&rft.coden=OPHTDG&rft_id=info:doi/10.1016/j.ophtha.2004.05.016&rft_dat=%3Cproquest_pubme%3E66766215%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66766215&rft_id=info:pmid/15288995&rft_els_id=S0161642004008176&rfr_iscdi=true |